Skip to main content

Table 4 Fracture-related healthcare resource utilization and costs †

From: Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study

Measure

12 month post period

24 month post period

Total Patients

222

134

Fracture-Related Inpatient Hospitalization

  

  Members with Hospitalization n,(%)

21 (9.5%)

11 (8.2%)

  Hospitalizations Per Member**

0.1 (± 0.4)

0.1 (± 0.4)

 

0 [0 - 2]

0 [0 - 2]

Fracture-Related Emergency Room Visits

  

  Members with Visit n,(%)

35 (15.8%)

33 (24.6%)

  Visits Per Member**

0.2 (± 0.5)

0.3 (± 0.6)

 

0 [0 - 3]

0 [0 - 3]

Fracture-Related Outpatient Visits

  

  Members with Visit n,(%)

213 (95.9%)

126 (94%)

  Visits Per Member**

4.1 (± 7.4)

4.6 (± 8.55)

2 [0 - 65]

2 [0 - 61]

Fracture-Related Pharmacy Claims

  

 Pain Medications

  

  Members with Pharmacy Claim n,(%)

161 (72.5%)

110 (82.1%)

  Pharmacy Claims Per Member**

5.6 (± 7.7)

9.2 (± 11.9)

2 [0 - 43]

4 [0 - 55]

Osteoporosis Medications

  

 Members with Pharmacy Claim n,(%)*

222 (100%)

134 (100%)

  Pharmacy Claims Per Member**

5.8 (± 4.5)

10. (± 8.7)

4 [1 - 18]

6 [1 - 29]

Total Fracture-Related Cost**

$6,198 (± $6,578)

$8,389 (± $8,650)

$3,260 [$854 - $40,637]

$3,944 [$854 - $47,033]

 Inpatient Hospitalization Cost**

$1,123 (± $4,506)

$967 (± $3,582)

$0 [$0 - $37,355]

$0 [$0 - $22,387]

 Emergency Room Visit Cost**

$35 (± $117)

$100 (± $674)

$0 [$0 - $753]

$0 [$0 - $7,692]

 Outpatient Cost**

$829 (± $2,297)

$1,007 (± $3,128)

$179 [$0 - $23,383]

$141 [$0 - $23,545]

 Osteoporosis Medication Cost**

$3,965 (± $3,640)

$6,061 (± $6,737)

$2,459 [$779 - $14,910]

$2,603 [$784 - $22,965]

 Pain Medication Cost**

$246 (± $758)

$253 (± $605)

$24 [$0 - $6,276]

$35 [$0 - $3,575]

  1. † Among patients with a fracture.
  2. *All patients with a fracture had an osteoporosis medication claim.
  3. **Mean, standard deviation, median, [range].